Relation is pioneering a “Lab-in-the-Loop” that can integrate active learning at every step of drug discovery, from predicting cell states to the validation of new targets. An important challenge for any therapeutics company using machine learning is “ground-truth data,” or information known to be true. Working from real cells provided by proprietary biobanks, Relation’s technology generates genomic data that provide direct insights into critical biological relationships that are fed directly into its ML systems. The platform then requests new experiments to improve its predictive ability, cutting through an otherwise intractable combinatorial space.
Location: United Kingdom
Employees: 11-50
Total raised: $196M
Founded date: 2019
Investors 2
| Date | Name | Website |
| 03.06.2022 | DCVC | dcvc.com/ |
| - | Realm Capi... | realmcapit... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 30.07.2026 | - | $110M | - |
| 11.12.2025 | - | $26M | - |
| 15.03.2024 | Seed | $35M | DCVC |
| 16.06.2022 | Seed | $25M | - |
Persons 18
| Date | First Name | Last Name | Title | Location | |||
| - | Jake P. | Taylor-Kin... | Chief Inno... | linkedin.c... | - | j**e@relat... | - |
| - | Thomas | Gaudelet | Associate ... | linkedin.c... | - | t*********... | - |
| - | Jeremy | Hayter | Operations... | linkedin.c... | - | j****y@rel... | - |
| - | Lindsay | Edwards | Chief Tech... | linkedin.c... | - | l*****y@re... | - |
| - | Aga | Dobrowolsk... | Machine Le... | linkedin.c... | - | a*a@relati... | - |
| - | Cristian | Regep | Senior Dir... | linkedin.c... | - | c******n@r... | - |
| - | Lorenzo | Ramos-Mucc... | Senior Sci... | linkedin.c... | - | l*****o@re... | - |
| - | Thomas | Watson | ML and Eng... | linkedin.c... | - | t****s@rel... | - |
| - | David | Roblin | Chief Exec... | linkedin.c... | - | d***d@rela... | - |
| - | Maria | New | - | linkedin.c... | - | M***a@rela... | - |
Show more
Mentions in press and media 8
| Date | Title | Description |
| 30.07.2026 | GSK Backs Relation Therapeutics With $110M to Build Biological Data Factory | By James Whitaker Published: Jul 30 2026, 10:00 AM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 11.12.2025 | Relation Raises Additional $26M Investment | Relation, a London, UK-based biopharmaceutical company, raised additional $26M in funding. Backers included NVentures, DCVC and Magnetic Ventures. The company intends to use the funds to expand operations and its R&D efforts. Led by CEO... |
| 17.03.2024 | Relation Therapeutics: A Biotech Breakthrough | Relation Therapeutics, a London-based biotechnology company, has secured a whopping $35 million in new seed financing. The funding, led by DCVC and NVentures, with support from other key players in the industry, brings the company's total f... |
| 15.03.2024 | Relation Therapeutics Raises $35M in Seed Funding | Relation Therapeutics, a London, UK-based biotechnology company leveraging computational and experimental approaches to drug discovery, raised $35M in Seed funding. The round, which brought the total amount to $60M, was led by DCVC and NVen... |
| 14.03.2024 | Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm | - |
| 22.02.2023 | Relation Therapeutics Announces Launch Of Flagship Integrated Wet–dry Laboratory At The Heart Of London’s Knowledge Quarter | Edith Hessel, experienced R&D and biopharma executive, named as Chief Scientific Officer Osteoporosis announced as first indication, driven by Relation’s proprietary engine for indication selection Selectomatic Relation Therapeutics, a ... |
| - | Relation Therapeutics | “Discovering biology’s relationships, curing disease.” |
| - | Relation Therapeutics | “Relation uses machine learning to develop drugs for pressing unmet need.” |